Novo Nordisk A/S, BlackRock, and Prologis are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose earnings and revenues are expected to grow at an above-average rate compared to the overall market. These companies typically reinvest profits back into operations rather than paying high dividends, aiming to fund research, expansion, or acquisitions. Investors in growth stocks generally accept higher valuations and volatility in exchange for the potential of substantial capital appreciation. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Novo Nordisk A/S stock traded up $0.90 during midday trading on Friday, reaching $65.75. 13,058,660 shares of the stock were exchanged, compared to its average volume of 6,383,307. The firm has a market cap of $295.06 billion, a PE ratio of 19.98, a PEG ratio of 0.90 and a beta of 0.65. Novo Nordisk A/S has a 52 week low of $57.00 and a 52 week high of $148.15. The company's fifty day moving average is $69.21 and its 200-day moving average is $86.03. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.55 and a current ratio of 0.74.
Read Our Latest Research Report on NVO
BlackRock (BLK)
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
Shares of BlackRock stock traded down $5.16 on Friday, hitting $923.48. 684,779 shares of the company traded hands, compared to its average volume of 686,149. The company has a current ratio of 5.23, a quick ratio of 5.23 and a debt-to-equity ratio of 0.45. The firm's 50-day simple moving average is $913.01 and its 200 day simple moving average is $978.44. BlackRock has a 12-month low of $752.30 and a 12-month high of $1,084.22. The company has a market cap of $143.37 billion, a P/E ratio of 21.99, a P/E/G ratio of 1.90 and a beta of 1.41.
Read Our Latest Research Report on BLK
Prologis (PLD)
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
Prologis stock traded up $1.48 during mid-day trading on Friday, hitting $106.97. The company's stock had a trading volume of 5,505,774 shares, compared to its average volume of 4,161,857. The stock has a market cap of $99.26 billion, a price-to-earnings ratio of 26.74, a price-to-earnings-growth ratio of 2.70 and a beta of 1.25. Prologis has a 12 month low of $85.35 and a 12 month high of $132.57. The business has a 50 day moving average price of $105.95 and a 200-day moving average price of $111.37. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.75 and a quick ratio of 0.43.
Read Our Latest Research Report on PLD
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novo Nordisk A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.
While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
